EquityBulls

Latest News

Keywords Selected: USFDA

Stock Report

Jubilant's Radiopharma business receives NDA approval for Technetium Mertiatide Injection
Lupin receives Tentative Approval from U.S. FDA for Dolutegravir, Emtricitabine and Tenofovir Alafenamide Tablets
USFDA concludes inspection at Solara's Visakhapatnam facility with Zero 483 inspectional observations
US FDA Inspection at JNPC Facility, Visakhapatnam of Gland Pharma Ltd
Zydus Lifesciences Ltd successfully completes USFDA inspection at Moraiya facility
Glenmark Pharmaceuticals Ltd updates on Baddi facility
Granules Pharmaceuticals Inc., receives ANDA Approval for Amphetamine Mixed Salts ER Capsules
USFDA inspection at Indoco Remedies Limited's Solid Oral Formulation Facility - Plant 1 at Goa
Laurus Labs Ltd receives EIR from USFDA for Unit 5, Parawada, Vizag
Alembic Pharmaceuticals receives USFDA Tentative Approval for Acalabrutinib Capsules, 100 mg
Stelis Biopharma's flagship facility receives EIR from the USFDA
Lupin receives Tentative Approval from U.S. FDA for Dolutegravir and Rilpivirine Tablets
Zydus receives tentative approval from the USFDA for Levomilnacipran Extended-Release Capsules
Lupin gets 2 observations from USFDA for Somerset facility
Granules India Ltd gets 3 observations from USFDA for Gagillapur facility
Zydus receives final approval and 180 days shared exclusivity from the USFDA for Brexpiprazole Tablets
Piramal Pharma Ltd gets 6 observations from USFDA for Lexington facility
Zydus receives final approval from the USFDA for Febuxostat Tablets
Lupin receives approval from U.S. FDA for Prasugrel Tablets, USP
Biocon Biologics Statement on Complete Response Letter from USFDA
Lupin receives approval from U.S. FDA for Fesoterodine Fumarate Extended-Release Tablets
Alembic Pharmaceuticals receives USFDA Final Approval for Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg
Gland Pharma Ltd updates on US FDA Inspection at Dundigal Facility, Hyderabad
Eugia Pharma receives USFDA approval for Azacitidine for Injection